SUR1/Kir6.2 potassium channel a new actor involved in pulmonary arterial hypertension

H. Le Ribeuz (Le Kremlin Bicetre, France), M. Lambert (Le Kremlin Bicetre, France), A. Boet (Le Kremlin Bicetre, France), D. Montani (Le Kremlin Bicetre, France), W. Chung (New York, United States of America), M. Humbert (Le Kremlin Bicetre, France), F. Antigny (Le Kremlin Bicetre, France)

Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Session: Pathophysiology of pulmonary hypertension
Session type: E-poster session
Number: 3561
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Le Ribeuz (Le Kremlin Bicetre, France), M. Lambert (Le Kremlin Bicetre, France), A. Boet (Le Kremlin Bicetre, France), D. Montani (Le Kremlin Bicetre, France), W. Chung (New York, United States of America), M. Humbert (Le Kremlin Bicetre, France), F. Antigny (Le Kremlin Bicetre, France). SUR1/Kir6.2 potassium channel a new actor involved in pulmonary arterial hypertension. 3561

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Potassium channels in pulmonary arterial hypertension
Source: Eur Respir J 2015; 46: 1167-1177
Year: 2015



Role of NO pathway, calcium and potassium channels in the peripheral pulmonary vascular tone in dogs
Source: Eur Respir J 2001; 17: 20-26
Year: 2001



Loss of response to calcium channel blockers after long-term follow up in idiopathic pulmonary arterial hypertension
Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension
Year: 2020


Dehydroepiandrosterone sulphate reduces chronic hypoxic pulmonary hypertension in rats
Source: Eur Respir J 2003; 21: 862-865
Year: 2003



The potential effects of pregnancy in a patient with idiopathic pulmonary arterial hypertension responding to calcium channel blockade
Source: Eur Respir J, 50 (6) 1701141; 10.1183/13993003.01141-2017
Year: 2017



Docosahexaenoic acid causes rapid pulmonary arterial relaxation via KCa channel-mediated hyperpolarisation in pulmonary hypertension
Source: Eur Respir J 2016; 48: 1127-1136
Year: 2016



Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2009; 33: 1354-1360
Year: 2009



Prediction of effects of calcium channel blockers (CCB) on hypoxic pulmonary hypertension (HPH) due to COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 268s
Year: 2003

CFTR involvement in the pathogenesis of pulmonary arterial hypertension
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020


Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension
Source: Eur Respir J, 58 (5) 2000653; 10.1183/13993003.00653-2020
Year: 2021



KCNK3 channel inactivation leads to pulmonary vascular alterations in rat
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018

Stable prostacyclin analogues treprostinil and iloprost activates KCa and two-pore domain TASK-1 channels in human pulmonary artery smooth muscle cells
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008

Current medical therapies in pulmonary arterial hypertension
Source: Eur Respir Mon 2012; 57: 26-41
Year: 2012


Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertension
Source: Eur Respir J, 53 (6) 1800965; 10.1183/13993003.00965-2018
Year: 2019



Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension
Source: Eur Respir J, 58 (2) 2101645; 10.1183/13993003.01645-2021
Year: 2021



Late Breaking Abstract - Involvement of Orai1 Ca2+ channel in the pathogenesis of pulmonary arterial hypertension. Orai1 as a new potential therapeutic target ?
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021


The pathophysiological roles of a voltage-gated potassium channel Kv1.5 in toluene diisocyanate-induced asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 29s
Year: 2002

Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension
Source: Eur Respir J, 56 (5) 2000522; 10.1183/13993003.00522-2020
Year: 2020



The emerging role of the contractile and vascular reserves in pulmonary arterial hypertension
Source: Eur Respir J 2015; 45: 1756-1758
Year: 2015


The emerging role of the contractile and vascular reserves in pulmonary arterial hypertension
Source: Eur Respir J 2015; 45: 1758-1759
Year: 2015